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Abstract
Background
A growing body of literature on Roux-en-Y gastric bypass surgery (RYGB) has generated
inconclusive results on the mechanism underlying the beneficial effects on weight loss and
glycaemia, partially due to the problems of designing clinical studies with the appropriate
controls. Moreover, RYGB is only performed in obese individuals, in whom metabolism is
perturbed and not completely understood.
Methods
In an attempt to isolate the effects of RYGB and its effects on normal metabolism, we inves-
tigated the effect of RYGB in lean pigs, using sham-operated pair-fed pigs as controls. Two
weeks post-surgery, pigs were subjected to an intravenous glucose tolerance test (IVGTT)
and circulating metabolites, hormones and lipids measured. Bile acid composition was pro-
filed after extraction from blood, faeces and the gallbladder.
Results
A similar weight development in both groups of pigs validated our experimental model.
Despite similar changes in fasting insulin, RYGB-pigs had lower fasting glucose levels. Dur-
ing an IVGTT RYGB-pigs had higher insulin and lower glucose levels. VLDL and IDL were
lower in RYGB- than in sham-pigs. RYGB-pigs had increased levels of most amino acids,
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including branched-chain amino acids, but these were more efficiently suppressed by glu-
cose. Levels of bile acids in the gallbladder were higher, whereas plasma and faecal bile
acid levels were lower in RYGB- than in sham-pigs.
Conclusion
In a lean model RYGB caused lower plasma lipid and bile acid levels, which were compen-
sated for by increased plasma amino acids, suggesting a switch from lipid to protein metab-
olism during fasting in the immediate postoperative period.
Introduction
Obesity increases at a pandemic rate. Consequently, the incidence of type 2 diabetes mellitus
(T2DM) increases. For long, conservative treatments, i.e. diet- and exercise-interventions,
have been the most common options to treat obesity and to reduce the risk of developing both
obesity and T2DM [1]. Accordingly, dietary changes have been fundamental in the treatment
of T2DM, most often with the aim of reducing caloric intake [2]. More recently, one week of a
strict low-calorie diet was shown to normalize glycaemia in obese T2DM patients [3].
Although the improvements in glycaemia were maintained as long as 12 weeks post interven-
tion, most diet- and exercise-interventions eventually fail to sustain long-term weight-loss [4].
Another, more invasive approach to induce weight-loss is bariatric surgery, which produces
greater and more sustainable weight-loss and a higher rate of T2DM remission than life-style
interventions [5]. Several different surgical techniques are available that reduce food intake
and in some cases believed also to induce malabsorption [6]. Currently, Roux-en-Y gastric
bypass surgery (RYGB) is the most common procedure, inducing both a reduction in food
intake and to some extent nutrient malabsorption. RYGB has been shown to yield a higher
degree of T2DM remission than most other available bariatric surgery procedures, both in the
short (days) [7] and in the long term (4 years) [8]. The mechanism underlying T2DM remis-
sion is under debate. On one hand, it has been suggested that T2DM remission is solely due to
reduced nutrient intake/malabsorption and weight-loss [9]. On the other hand, T2DM remis-
sion has been attributed to weight-loss-independent factors [8], such as altered circulating lev-
els of gut hormones [10], particularly GLP-1 [11], changes in gut microbiota [12], gut nutrient
sensing [13] and bile flow [14]. It has also been shown that plasma bile acid levels increase
after RYGB in both the short [14] and the long term [15]. Besides their established role to
improve digestion and lipid adsorption, bile acids also act on receptors, including the farne-
soid-X-receptor (FXR) [16], enhance energy expenditure [17] and stimulate secretion of hor-
mones such as GLP-1 [18]. However, the mechanism of bile acids in the improvement of
glycaemia has become even more complex due to studies revealing that treatment with bile
acid sequestrants, which increase faecal secretion of bile acids by disruption of their enterohe-
patic circulation, result in improved glycaemia in T2DM [19].
The impact of RYGB on metabolism in obese humans has been widely studied. However,
the metabolic perturbations associated with obesity are only partially understood, potentially
obscuring the mechanistic understanding of RYGB. We hypothesize that a clearer understand-
ing of the mechanism may be achieved by studying the impact of RYGB under normal and
healthy conditions. As it is unfeasible and unethical to perform such studies in humans, we
used a lean porcine model [20], showing a greater resemblance to human physiology than
rodents [21]. Pigs subjected to RYGB were compared with weight-matched, sham-operated,
RYGB in lean pigs
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pair-fed control pigs, which allowed us to compensate for surgery-related stress, weight loss
and nutrient intake. Although matching for nutrient intake is possible in human studies [9,
22], matching for confounding effects elicited by surgery per se is not feasible in humans.
Materials and methods
Animals
Experiments were performed with the approval of the Animal Ethics Committee of Lund Uni-
versity, Sweden (M128-12).
Weight-matched male juvenile landrace pigs [20] weighing 26±2.5 kg at the start of the
study, were randomly selected from the University herd at Odarslo¨v research farm (Swedish
Agricultural University, Alnarp, Sweden), transported to the animal facilities at the Depart-
ment of Cell and Organism Biology (Lund University, Lund, Sweden) and then kept in indi-
vidual pens with wood chips as bedding material. All pens were equipped with a dry feeding
trough, a drinking nipple and a constant heating lamp (150 W). Prior to surgery, pigs were fed
a standard diet (VA¨XTILL1, Lantma¨nnen, Sweden), at 4% of their body weight (approxi-
mately 2900 kcal) per day. The pens were cleaned and bedding material was replaced every
day.
Roux-en-Y gastric bypass surgery and postsurgical management
Pigs were chosen as a model as they are omnivorous, have a GI-tract similar to the human and
similar eating habits as humans. A time-line for the study is shown in Fig 1A.
Animals were subjected to either a standard limb RYGB (n = 9) or sham-surgery (n = 8)
through upper-midline incisions under general halothane anaesthesia at the animal facilities at
the Department of Cellular and Organism Biology as previously described in detail [20].
Briefly, a 12–15 ml gastric pouch was constructed by dividing the stomach 3 cm from the gas-
troesophageal transition. The jejunum was divided 60 cm distal to the duodenojejunal junc-
tion. A standard gastrojejunostomy and an enteroenterostomy were performed. Sham-surgery
was performed in control animals, with gentle manipulation of the bowel but without
transections.
Pigs were closely monitored, and treated prophylactically with ampicillin and buprenor-
phine until 3 days after surgery, as previously described in detail [20]. They were given three
meals per day of low-calorie diet (250 ml Modifast, Stocksund, Sweden; 220 kcal, 25E% pro-
tein, 52E% carbohydrates, and 21E% fat) [20]. All pigs consumed all food provided. Thereby
nutrient intake did not differ between pigs. Two RYGB-pigs died shortly after surgery; RYGB
survival rate was 80%. One RYGB-pig died from ruptured staple line and another from post-
operative swelling of an anastomosis. This number was within the anticipated range. At the
end of the study, all pigs were euthanized by an overdose of anaesthesia (halothane) and
injected with potassium chloride.
Blood sampling and intravenous glucose tolerance test
Two weeks after arrival to the animal facilities, three days preoperatively, baseline blood sam-
ples were obtained after an overnight fast. Two weeks post-surgery, pigs were subjected to a
frequently sampled IVGTT. The IVGTT was performed after an overnight fast using a glucose
bolus of 500 mg ml-1 (1 g kg-1). Blood was collected in pre-chilled EDTA tubes at indicated
time-points. Tubes were kept on ice until centrifugation (1500xg, 15 min, 4˚C) and plasma
stored at -80˚C until analysis. One catheter in one of the RYGB-pigs was clogged, whereby
only one fasted sample could be collected in this animal. This sample was used for analysis of
RYGB in lean pigs
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bile acids. Due to problems with the catheter in another RYGB-pig, some data points are lack-
ing. For two of the sham pigs, some samples were consumed prior to analysis of metabolite
profiles.
Fig 1. Changes in weight, insulin and glucose profiles after RYGB and sham-surgery. A: Time-line for the
study. B: Weight developed similarly in the two groups of animals. C: Insulin levels were increased and D: glucose
levels decreased in RYGB- compared with sham-pigs. E: Fasting glucose was higher in sham-pigs whereas insulin
did not differ between the groups. F: RYGB-pigs had a higher acute insulin response (AIR) and AUCinsulin/
AUCglucose-ratio compared with the sham-pigs. Data are expressed as mean±SEM for n = 5 for RYGB and n = 8 for
sham. Statistical differences were assessed by the two-way ANOVA in panels B, C and D, a one-way ANOVA in
panel E, and the two-tailed heteroscedastic Student’s t-test in panel F. *p<0.05, **p<0.01, ***p<0.001
doi:10.1371/journal.pone.0173137.g001
RYGB in lean pigs
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Glucose, insulin and cholecystokinin analysis
Plasma glucose was measured by the Infinity Glucose Oxidase kit (ThermoScientific, Lexing-
ton, MA) and insulin using a porcine ELISA (Mercodia, Uppsala, Sweden), according to the
manufacturers’ instructions. Cholecystokinin (CCK) was assayed by RIA [23]. HOMA-IR was
calculated as basal insulin (μIU ml-1) x basal glucose (mmol L-1)/22.5, HOMA-β as (20 x basal
insulin)/(basal glucose-3.5), and the acute insulin response (AIR) as mean insulin secretion for
the first 10 min of the IVGTT. Insulin sensitivity (cSi) was estimated as the 0.276 x (glucose
elimination rate / insulin AUC / 50), using data collected between 10 and 60 min of the
IVGTT [24].
Analysis of lipoprotein fractions and sub-fractions
Lipoprotein fractions and sub-fractions were separated based on size using Quantimetrix
Lipoprint1 system (Quantimetrix Corporation, Redondo Beach, CA) according to the manu-
facturers’ instructions. Briefly, 25 μl of fasted serum collected prior to the IVGTT were mixed
with 200 μl of loading gel and added to precast 3% polyacrylamide gel tubes. The mixture was
subsequently polymerized at room temperature for 35 min and samples electrophoresed for 1h
(3 mA per gel tube). Levels of cholesterol in each sub-fraction were calculated using the Lipo-
ware Clinical analysis software (Quantimetrix Corporation). Total serum cholesterol was mea-
sured by a colorimetric assay (InfinityTM-Cholesterol; Thermo Scientific, Middletown, VA)
as described previously [25].
Metabolite profiling
Metabolite profiling was performed on samples acquired at baseline, pre- and post-surgery,
and at 7 and 120 minutes during the IVGTT. Metabolites were analysed by GC/MS, as previ-
ously described in detail [26].
Bile acid analysis
Samples for analyses of bile acids in plasma, faeces and bile were taken at sacrifice, after an
overnight fast (15 hours), and 15 days post-surgery. Bile acids in plasma were extracted as pre-
viously described in detail [27]. Bile acids from faeces were extracted after homogenizing in 2
ml propylene tubes with zirconium oxide beads. Approximately 50 mg of faeces was placed in
the tube and 500 μl methanol containing 2.5 μmol l-1 of internal standards was added. The
sample was homogenized using a TissueLyser II (Qiagen, Hilden, Germany) at 25 Hz for 10
minutes. The homogenate was then centrifuged at 20 000xg for 10 minutes and 20 μl of the
supernatant was diluted to 1000 μl with water/methanol (1/1; v/v). Bile acids from 50 μl of bile
taken from the gallbladder using a syringe and needle were extracted by adding 500 μl metha-
nol. After mixing and centrifugation the supernatant was diluted 1000-fold with water/metha-
nol (1/1; v/v). Internal standards were added after the dilution. Extracted bile acids were
analysed as previously described in detail [27].
Statistical analysis
Hormone, metabolite and bile acid data are presented as mean ± SEM. Lipoprint and metabo-
lite profiling data were mean centred and unit variance scaled and analysed by orthogonal pro-
jections to latent structures discriminant analysis (OPLS-DA) in Simca P+ 12 (Umetrics,
Umeå, Sweden). AUC was calculated in GraphPad Prism 5 (GraphPad Software, San Diego,
CA). Unpaired two-tailed Student’s t-test was used to assess statistical differences between
RYGB- and sham-pigs and paired two-tailed Student’s t-test to assess differences between pre-
RYGB in lean pigs
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and post-surgical levels in the two different groups of animals. ANOVA was used when several
groups were compared. P-values of< 0.05 were considered significant.
Results
IVGTT-elicited plasma glucose levels are lower and insulin levels higher
in RYGB- compared with sham-pigs
Body weight did not differ significantly between groups at any time of the study (Fig 1B, S1
Table). At the end of the study, RYGB-pigs weighed 28.9±1.9 kg and sham-pigs 29.6±1.3 kg.
Insulin levels were higher (p<0.001) and glucose levels lower (p<0.001) during an IVGTT in
the RYGB- compared with the sham-pigs (Fig 1C and 1D, S2 Table). Fasting glucose concentra-
tions were 29% lower (p<0.01) in RYGB- compared with sham pigs, whereas fasting insulin did
not differ between groups (Fig 1E). However, this between group difference was largely driven by
a more pronounced increase in plasma glucose in the sham-pigs, which is likely a result from dif-
ferences in diets and feeding protocols between pre- and post surgical care. Glucose elimination
rate and peak glucose levels did not differ significantly between RYGB- and sham-pigs. Measures
of β-cell secretory response, i.e. AIR and AUCinsulin/AUCglucose-ratio, were 3.3-fold (p<0.01) and
2-fold (p<0.05), respectively, greater in RYGB- compared with sham-pigs (Fig 1F). HOMA-IR
(RYGB, pre 0.016±0.0039, post 0.017±0.0049; sham, pre 0.017±0.0033, post 0.020±0.0038), cSi
(RYGB, post 1.16±0.62 10−4 min-1 [μU/ml]-1; sham, post 3.23±0.83 10−4 min-1 [μU/ml]-1)
HOMA-β (RYGB, pre 0.44±0.062, post 0.35±0.17; sham, pre 0.47±0.10, post 0.16±0.045) and
plasma CCK levels (RYGB, post 0.93±0.10 pmol/L; sham, post 0.89±0.19 pmol/L) did not differ
between the two groups.
Reduced levels of VLDL-remnants and IDL particles in RYGB-
compared with sham-pigs
Differences in fasting lipoprotein content and composition between RYGB- and sham-pigs
were analysed by OPLS-DA (S3 Table). OPLS-DA has the ability to separate predictive varia-
tion from variation that is uncorrelated to the investigated variable, thereby filtering out
unwanted variation in the data. Here, OPLS-DA was used to exclude variation in the data
unrelated to the surgical procedure, thereby focusing the analysis on alterations in the lipopro-
tein profile caused by RYGB. The score-scatter plot (Fig 2A) revealed that samples clustered
according to whether they were derived from a RYGB- or a sham-pig. Differences in parame-
ters underlying the observed clustering are visualized in the loading plot (Fig 2B). Hence, most
lipoprotein fractions were lower in RYGB- compared with sham-pigs. Results from the
OPLS-DA analysis were confirmed by univariate statistics, revealing lower levels of VLDL
(-33%, p<0.01) and IDL-1 (large IDL; -36%, p<0.05) in RYGB- compared with sham-pigs
(Fig 2C).
Fasting amino acid levels increase after RYGB
Next, we analysed changes in fasting metabolite levels before and after RYGB or sham-surgery
(S4 Table) by OPLS-DA; one model was calculated for the RYGB-pigs and one for the sham-
pigs with sampling time, before or after surgery, as response (S1 Fig). The loadings from these
models, scaled as correlations, were subsequently combined in a shared and unique structures
(SUS) plot [28] (S1 Fig). From this plot, alterations in fasting metabolite levels elicited by either
RYGB or sham-surgery could be identified. Interestingly, levels of several metabolites changed
in opposite directions after RYGB and after sham-surgery. Thus, levels of the majority of
amino acids increased after RYGB, whereas levels of all but four amino acids were decreased
RYGB in lean pigs
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after sham-surgery. Furthermore, levels of NEFAs were unaffected by RYGB, but increased
after sham-surgery. Notably, the branched-chain amino acids (BCAAs) valine, leucine and iso-
leucine decreased only after sham-surgery. Decreased levels of cysteine were seen after both
RYGB and sham-surgery.
Finally, we validated findings from the OPLS-DA models using ANOVA (Fig 3). Four
amino acids, isoleucine (1.7-fold, p<0.05), leucine (1.6-fold, p<0.05), glutamate (2.0-fold,
p<0.05) and tryptophan (2.7-fold, p<0.01) were higher after RYGB than after sham-surgery
(Fig 3). In addition to the amino acids, urea (1.8-fold, p<0.05) was higher after RYGB than
after sham-surgery. Cysteine levels decreased significantly only after RYGB (-37%, p<0.05).
These changes were driven by both a decrease in levels in sham-pigs and increased levels in
RYGB-pigs. Notably, there was an association between a larger weight loss and higher post-
surgery fasting levels of the amino acids glutamate, histidine, lysine, leucine and tryptophan
and the fatty acids C12:0, C14:0, C20:4, and C22:6 (p<0.05).
Enhanced suppression of amino acid levels by glucose in RYGB-pigs
We then investigated alterations in the metabolite profile elicited by administration of an
intravenous glucose bolus. Calculation of AUCs for metabolites over fasting levels during the
Fig 2. Lipoprotein subfractions after RYGB and sham-surgery. A: Lipoprotein data from RYGB- and sham-
pigs were analysed by OPLS-DA to eliminate variation unrelated to the type of surgery. The score-scatter plot
reveals that samples cluster depending on type of surgery. B: According to the loadings of the OPLS-DA model,
with jack-knifed confidence intervals, levels of VLDL, large IDL and small-dense LDL-3 were lower after RYGB. C:
Analysis of the raw data revealed lower levels of VLDL and large IDL cholesterol in RYGB-pigs. Data is expressed
as mean±SEM for n = 6 for RYGB and n = 8 for sham in panel (c). Statistical differences were assessed by
ANOVA followed by Tukey’s test post hoc. *p<0.05, **p<0.01. R2(Y) = 0.64 and Q2(Y) = 0.43 for the OPLS-DA
model.
doi:10.1371/journal.pone.0173137.g002
RYGB in lean pigs
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IVGTT (Fig 4, S4 Table) revealed that glucose-elicited suppression of amino acid levels was
more efficient in RYGB-pigs than in sham-pigs. Hence, the AUCs of the BCAAs isoleucine
(p<0.05), leucine (p<0.01) and valine (p = 0.052), as well as the amino acids lysine (p<0.05),
serine (p<0.05), proline (p<0.05), threonine (p<0.05), tyrosine (p<0.05), tryptophan
(p<0.05), and asparagine (p<0.05) were lower in RYGB-pigs than in sham-pigs. Also suppres-
sion of urea levels during the IVGTT was more pronounced in RYGB-pigs than in sham-pigs
(p<0.05). The AUCs for threonine, tryptophan, asparagine, ornithine, creatinine (all p<0.05),
an arginine product (p<0.01), and urea (p = 0.54) were associated with a higher glucose level
at 120 min of the IVGTT. Hence, in the RYGB-pigs, with their lower glucose levels, amino
acid levels were more effectively suppressed.
RYGB causes increased gallbladder bile acids and reduced plasma and
faecal bile acid levels
Our result revealed lower fasting lipid levels in RYGB-pigs compared with sham-pigs. To
investigate whether this was related to changes in bile acid discharge we profiled fasting bile
acids in plasma, faeces and in bile from the gallbladder (S5 Table). These analyses showed that
RYGB-pigs had lower levels of all identified bile acids in plasma (-64% to -78%, p<0.05) and
faeces (-57% to -81%, p<0.05), resulting in 81% (p<0.05) and 65% (p<0.05) lower total bile
acid levels in plasma and faeces (Fig 5A and 5B, respectively). Total gallbladder bile acid levels
trended to be higher in RYGB-pigs compared with sham-pigs (1.7-fold, p = 0.060) and the lev-
els of all identified bile acids were 4.2- to 16-fold elevated (p<0.05) in the gallbladder bile of
RYGB-pigs (Fig 5C). Gallbladder volume, estimated from total bile weight, did not differ
between RYGB-pigs (37.7±6.1 g) and sham-pigs (29.6±2.2 g).
Discussion
RYGB has been shown to cause remission of T2DM in the majority of patients [5, 8]. However,
the mechanism underlying improved glucose metabolism has remained elusive. We chose to
perform these experiments in a non-diabetic, non-obese pig model of RYGB rather than in an
obese diabetic model. The purpose was to investigate the physiology of this procedure in the
absence of confounding influence from T2DM and obesity and to enable pair-feeding for the
elimination of differences in nutrient intake.
Fig 3. Alterations in fasted metabolite levels after RYGB and sham-surgery. Levels of multiple amino
acids are higher in RYGB-pigs than in sham-pigs. Data are presented as mean±SEM for n = 6 for RYGB and
n = 8 for sham. Statistical differences were assessed by the ANOVA, with pigs nested in surgical procedure,
using Tukey’s test post hoc. *p<0.05, **p<0.01, ***p<0.001.
doi:10.1371/journal.pone.0173137.g003
RYGB in lean pigs
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Both groups of pigs were weight stable during the test period. Hence, weight loss did not
differ between RYGB-pigs and sham-pigs. However, due to large individual variation in weight
between pigs the study is underpowered to detect small weight differences. Nevertheless,
RYGB-pigs had lower fasting glucose, as well as higher insulin and lower glucose levels during
an IVGTT compared with sham-pigs. In agreement with our previous study using this model
[20] RYGB-pigs also displayed enhanced β-cell function. Insulin resistance and sensitivity,
approximated by HOMA-IR and cSi, respectively, did not differ between groups. This observa-
tion is in concordance with a previous study on RYGB in lean Ossabaw miniature swine [29].
In the present study, we do not observe the expected improvement in insulin sensitivity after
RYGB [30]. However, it has been shown that severe starvation reduces insulin sensitivity [31].
Hence, as the pigs used in the present study are lean, they may be more sensitive to starvation,
as compared with the obese individuals that are usually subjected to RYGB.
A central aim of the present study was to extend findings of the effects of RYGB on glucose
metabolism to other metabolic pathways starting with lipoprotein metabolism. We found
lower levels of VLDL and large IDL in RYGB-pigs than in sham-pigs, confirming previous
clinical studies that have reported lower circulating total and LDL cholesterol concentrations
after RYGB [31]. Detailed investigations on different lipoprotein fractions have been lacking
and a significant reduction in these major triglyceride-containing lipoproteins in fasted
Fig 4. Alterations in metabolite levels elicited by an IVGTT in RYGB- and sham-operated pigs.
Metabolite AUCs, calculated over fasted levels during the IVGTT after RYGB and sham-surgery, reveal a
more pronounced glucose-elicited suppression of amino acids in RYGB-pigs compared with sham-pigs. Data
is presented as mean±SEM for n = 6. Statistical differences were assessed by the two-tailed heteroscedastic
Student’s t-test. *p<0.05, **p<0.01. Abbreviations in supplementary material S1 Table.
doi:10.1371/journal.pone.0173137.g004
RYGB in lean pigs
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subjects have not been previously observed. Hypertriglyceridemia has long been recognized as
an independent risk factor for cardiovascular disease, but it is the small VLDLs and IDLs, tri-
glyceride-rich remnant lipoproteins that have emerged as the actual atherogenic agents [32].
IDLs have been shown to accumulate in atherosclerotic plaques in vivo [33] and play a role in
the progression of atherosclerosis [34]. Taken together, our results show beneficial effects of
Fig 5. Faecal, circulating and gallbladder bile acid levels after RYGB and sham-surgery. A: Circulating
levels of bile acids are reduced in RYGB-pigs compared with sham-pigs. B: Faecal bile acid levels are lower in
RYGB-pigs compared with sham-pigs. C: Levels of bile acids are higher in bile from the gallbladder of RYGB-pigs
compared with sham-pigs. Data is presented as mean±SEM for n = 7 for RYGB and n = 8 for sham. Statistical
differences were assessed by the two-tailed heteroscedastic Student’s t-test. *p<0.05, **p<0.01.
doi:10.1371/journal.pone.0173137.g005
RYGB in lean pigs
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RYGB on lipid metabolism, beyond those expected from weight-loss alone; possibly contribut-
ing to the reported reduced risk of cardiovascular disease [35].
Next, we examined the impact of RYGB on the plasma metabolite profile. Levels of several
amino acids, including the BCAAs, and urea were higher in RYGB-pigs than in sham-pigs.
Moreover, a large weight loss was associated with higher levels of most of these amino acids.
Previous studies have shown BCAAs to decrease at one [22], three and six months [36] after
RYGB. However, the impact of RYGB on BCAA levels is complex, as levels of these amino
acids have been shown to associate with obesity and insulin resistance [37] as well as being
reduced in response to a reduction in nutrient intake [38], but increased in response to starva-
tion [39]. Moreover, BCAAs also decrease after non-operative weight loss interventions [38],
although to a lesser extent than after RYGB [22, 38]. Hence, increased levels of amino acids
observed in the RYGB-pigs may be due to starvation, which is in line with the observed trend
towards lower insulin sensitivity in these pigs. Levels of amino acids and urea were also more
efficiently suppressed by glucose in the RYGB-pigs. As opposed to the fasting levels, the
improved suppression is likely mediated by insulin, the secretion of which is enhanced in
response to glucose. As insulin sensitivity did not vary between groups, lower circulating lipid
and glucose levels and higher amino acid and urea levels in RYGB-pigs compared with sham-
pigs may suggest a more severe starvation in these pigs that, as opposed to previous studies in
humans, were non-obese and had a normal metabolism at baseline.
Finally, we examined the impact of RYGB on bile acid levels. We found massively reduced
levels of faecal and circulating bile acid levels in RYGB-pigs. Importantly, these alterations
were associated with increased gallbladder bile acid levels in the RYGB-pigs, despite similar
gallbladder volume as in the sham-pigs. These differences indicate that bile discharge may be
disrupted in the RYGB-pigs, which in turn would impact on lipid emulsification and uptake.
Opposite to what we observe here, circulating bile acid levels have previously been shown to be
increased after RYGB in obese patients [14, 40], an effect that was attributed to enhanced reab-
sorption of bile in the terminal ileum [14] and changes in bile acid synthesis [40]. Despite this,
malabsorption of lipids have been observed at six months, but not at one year, post RYGB
[41], and malabsorption of both lipids and protein at 5 and 14 month after long-limb RYGB
[42] where massive amounts of small intestine had been bypassed. Unfortunately, we lacked
sufficient amounts of faeces to investigate faecal lipid content. Our data do however not sup-
port increased bile acid absorption, as this would be expected to result in elevated plasma bile
acid levels.
We did not observe any differences in fasting CCK-levels, a major determinant of bile
secretion, between RYGB- and sham-pigs, but cannot exclude an altered response to feeding,
which could have been revealed by an OGTT or a mixed-meal test. Mixed-meal-elicited CCK
secretion has been shown to be lower after RYGB compared with sleeve gastrectomy, which
induce similar reduction in food intake, but have different impact on nutrient levels in the
duodenum [43]. On the other hand, meal-elicited circulating CCK levels have also been shown
to increase after RYGB [30]. The impact of RYGB on CCK and bile acids in lean humans is
unknown.
There are some limitations to the study. Firstly, we cannot rule out that changes in metabo-
lism are caused by altered insulinization of the liver and insulin clearance. Increased insulin
clearance has previously been suggested to result in an underestimation of insulin levels fol-
lowing RYGB in humans [44]. Secondly, we cannot rule out an influence from alterations in
the gut microbiota, which has emerged as an important regulator of host metabolism [45], and
has been shown to be altered by RYGB [27]. Thirdly, differences in feeding protocols between
pre and post-surgical care are likely to have impacted on the results. In fact, this is the case also
with most clinical studies addressing the impact of RYGB on metabolism.
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In summary, our findings explore the impact of RYGB in lean animals. Notably, reduced
circulating and faecal bile acid levels, reduced circulating lipid levels and increased circulating
amino acid and urea levels in RYGB-pigs suggest a potential impact of RYGB on macronutri-
ent utilization. The findings differ to some extent from what has been found in clinical studies
on RYGB for obesity. Whether our observed changes remain over time, possibly impacting
metabolism in patients reaching normal weight is unknown.
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